The cell surface expression of CD49f, but not CD29 and CD104, was downregulated by imatinib treatment in Ph‐positive ALL cell lines, but not in their T315I‐acquired sublines. The gene discussed is ITGB4; the disease is acute lymphoblastic leukemia.